High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients

Working Group CLEO

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences